Company ProfilePremium

AKORN, INCORPORATED

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
AKORN, INCORPORATED - Healthcare showcase

Year Founded & Workforce

1948

2,191 Employees

Industry

Healthcare

Services

Ophthalmics
A

AKORN, INCORPORATED Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

AKORN, INCORPORATED Overview

Company Headquarters: Illinois, US

Founded: 1948

Workforce: ~2,191

Company Working: Akorn, Incorporated is a specialty generic pharmaceutical company that develops, manufactures, and markets generic and branded prescription pharmaceuticals, branded as well as private-label over-the-counter consumer health products, and animal health pharmaceuticals. The company develops, manufactures, and markets specialized in generic pharmaceutical products in alternative dosage forms. It focuses on difficult-to-manufacture sterile and non-sterile dosage forms including ophthalmic, injectables, oral liquids, topicals, inhalants, and nasal sprays. It operates through two reportable segments, namely, prescription pharmaceuticals and consumer health.

Strategy

Akorn, Incorporated is currently planning to expand and maintain its customer base. Additionally, the company is significantly increasing the adoption of healthcare imaging cloud-based solutions to provide secure access to more than 26 million medical images across the globe via Vue cloud services. It also restructured each of its businesses to streamline reporting and decision-making, encouraging team members at every level to drive a more agile and results-driven organization. In the coming years, it aims to be a trusted partner to all stakeholders, including service providers, patients, regulators, and shareholders.

Company Snapshot

$1,116.8M

Revenue

2,191

Employees

1948

Founded

Illinois, US

Headquarters

SWOT Analysis

Strengths

  • The eye health supplement, TheraTears is highly recommended by eye professionals all over the world
  • Supports nutrition science education by conducting and participating in seminars and workshops
  • Tie-ups with several distributors in North America, Europe, Oceania, Asia, and the Middle East

Weaknesses

  • Focus on too many segments

Opportunities

  • Global penetration through mergers and acquisitions
  • Product portfolio expansion

Threats

  • Increasing competition from other companies in developing markets
  • Government regulations regarding health issues and interventions
  • Increasing competition
  • Price fluctuations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • AKORN, INCORPORATED
    • Ophthalmics

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales fell from USD 1,116.8 Mn in 2016 to USD 694 Mn in 2018.
AKORN, INCORPORATED — By Business Segment
Series (USD Mn)201620172018
Sales1,116.8841694

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.